132 related articles for article (PubMed ID: 37899073)
1. Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.
Inoue H; Yamamoto K; Shimamura Y; Azuma D; Ushikubo K; Okada H; Kimoto Y; Nishikawa Y; Tanaka I; Tanabe M; Onimaru M; Navarro MJ
Dig Endosc; 2024 Jun; 36(6):690-698. PubMed ID: 37899073
[TBL] [Abstract][Full Text] [Related]
2. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study.
Yoo IK; Ko WJ; Kim HS; Kim HK; Kim JH; Kim WH; Hong SP; Yeniova AÖ; Cho JY
Surg Endosc; 2020 Mar; 34(3):1124-1131. PubMed ID: 31139995
[TBL] [Abstract][Full Text] [Related]
3. First Experience with Banded Anti-reflux Mucosectomy (ARMS) for GERD: Feasibility, Safety, and Technique (with Video).
Hedberg HM; Kuchta K; Ujiki MB
J Gastrointest Surg; 2019 Jun; 23(6):1274-1278. PubMed ID: 30734179
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
Sumi K; Inoue H; Kobayashi Y; Iwaya Y; Abad MRA; Fujiyoshi Y; Shimamura Y; Ikeda H; Onimaru M
Dig Endosc; 2021 Mar; 33(3):347-354. PubMed ID: 32415898
[TBL] [Abstract][Full Text] [Related]
5. Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study.
Inoue H; Tanabe M; de Santiago ER; Abad MRA; Shimamura Y; Fujiyoshi Y; Ueno A; Sumi K; Tomida H; Iwaya Y; Ikeda H; Onimaru M
Endosc Int Open; 2020 Feb; 8(2):E133-E138. PubMed ID: 32010745
[No Abstract] [Full Text] [Related]
6. Short and long term effect of anti-reflux mucosectomy with cap-assisted endoscopic mucosal resection for refractory gastroesophageal disease.
Lee YS; Kim JH; Yon DK; Yoo IK
Surg Endosc; 2024 Apr; 38(4):2180-2187. PubMed ID: 38448622
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study (with video).
Patil G; Dalal A; Maydeo A
Dig Endosc; 2020 Jul; 32(5):745-752. PubMed ID: 31834663
[TBL] [Abstract][Full Text] [Related]
8. Does the presence of an esophageal motor disorder influence the response to anti-reflux mucosectomy (ARMS) for refractory GERD?
Onana Ndong P; Gonzalez JM; Beyrne A; Barthet M; Vitton V
Scand J Gastroenterol; 2024 Jun; 59(6):639-646. PubMed ID: 38497142
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of endoscopic anti-reflux mucosectomy and stretta radiofrequency ablation in the management of gastroesophageal reflux disease: insights from a retrospective multicenter cohort study.
Lee AY; Kim SH; Cho JY
Surg Endosc; 2024 Jun; ():. PubMed ID: 38866947
[TBL] [Abstract][Full Text] [Related]
10. Objective Outcomes of an Extended Anti-reflux Mucosectomy in the Treatment of PPI-Dependent Gastroesophageal Reflux Disease (with Video).
He J; Yin Y; Tang W; Jiang J; Gu L; Yi J; Yan L; Chen S; Wu Y; Liu X
J Gastrointest Surg; 2022 Aug; 26(8):1566-1574. PubMed ID: 35776296
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic management of gastroesophageal reflux disease: Panacea for proton pump inhibitors dependent/refractory patients.
Kalapala R; Singla N; Reddy DN
Dig Endosc; 2022 May; 34(4):687-699. PubMed ID: 34651353
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic anti-reflux mucosectomy (ARMS) and endoscopic anti-reflux ablation (ARMA) as a potential treatment for gastroesophageal reflux - preliminary report.
Klimczak T; Strzelczyk J
Pol Przegl Chir; 2023 Oct; 96(0):1-5. PubMed ID: 38348994
[TBL] [Abstract][Full Text] [Related]
13. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
14. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
[TBL] [Abstract][Full Text] [Related]
15. Antireflux Mucosectomy Band (ARM-b) in Treatment of Refractory Gastroesophageal Reflux Disease After Bariatric Surgery.
Debourdeau A; Vitton V; Monino L; Barthet M; Gonzalez JM
Obes Surg; 2020 Nov; 30(11):4654-4658. PubMed ID: 32676843
[TBL] [Abstract][Full Text] [Related]
16. Frontiers in Endoscopic Treatment for Gastroesophageal Reflux Disease.
Ota K; Takeuchi T; Higuchi K; Sasaki S; Mori Y; Tanaka H; Hakoda A; Sugawara N; Iwatsubo T; Nishikawa H
Digestion; 2024; 105(1):5-10. PubMed ID: 37591209
[TBL] [Abstract][Full Text] [Related]
17. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study.
Shimamura Y; Inoue H; Tanabe M; Ushikubo K; Yamamoto K; Kimoto Y; Nishikawa Y; Ando R; Sumi K; Navarro MJ; Teruel Sanchez-Vegazo C; Peñas B; Parejo S; Martínez Sánchez A; Vazquez-Sequeiros E; Onimaru M; Albillos A; Rodriguez de Santiago E
J Gastroenterol Hepatol; 2024 Jan; 39(1):149-156. PubMed ID: 37787176
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial.
Kalapala R; Karyampudi A; Nabi Z; Darisetty S; Jagtap N; Ramchandani M; Gupta R; Lakhtakia S; Goud R; Venkat Rao G; Sharma P; Reddy DN
Gut; 2022 Apr; 71(4):686-694. PubMed ID: 33849942
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years.
Ota K; Takeuchi T; Kojima Y; Sugawara N; Nishida S; Iwatsubo T; Kawaguchi S; Harada S; Tokioka S; Higuchi K
BMC Gastroenterol; 2021 Nov; 21(1):432. PubMed ID: 34794376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
